Curcumin-induced upregulation of the anti-tau cochaperone BAG2 in primary rat cortical neurons

Sachin P. Patil, Nhung Tran, Hirosha Geekiyanage, Li Liu, Christina Chan

    Research output: Research - peer-reviewArticle

    • 21 Citations

    Abstract

    Alzheimer's disease (AD) is a progressive, neurodegenerative disease characterized by extracellular deposits of amyloid beta (Aβ) protein and intracellular neurofibrillary tangles of hyperphosphorylated tau protein. Various studies suggest that the tau tangle pathology, which lies downstream to Aβ pathology, is essential to produce AD-associated clinical phenotype and thus treatments targeting tau pathology may prevent or delay disease progression effectively. In this context, our present study examined three polyphenol compounds (curcumin, EGCG and resveratrol) for their possible activity against two endogenous proteins (BAG2 and LAMP1) that are shown to play a vital role in clearing tau tangles from neurons. Human epidemiological and animal data suggest potential positive effects of these polyphenols against AD. Here, primary rat cortical neurons treated with these polyphenols significantly up-regulated BAG2 levels at different concentrations, while only EGCG upregulated LAMP1 levels, although at higher concentrations. Importantly, curcumin doubled BAG2 levels at low micromolar concentrations that are clinically relevant. In addition, curcumin also downregulated levels of phosphorylated tau, which may be potentially attributed to the curcumin-induced upregulation in BAG2 levels in the neurons. The present results demonstrate novel activity of polyphenol curcumin in up-regulating an anti-tau cochaperone BAG2 and thus, suggest probable benefit of curcumin against AD-associated tauopathy.

    LanguageEnglish (US)
    Pages121-125
    Number of pages5
    JournalNeuroscience Letters
    Volume554
    DOIs
    StatePublished - Oct 25 2013

    Profile

    Curcumin
    Up-Regulation
    Neurons
    Polyphenols
    Alzheimer Disease
    Pathology
    Lysosomal-Associated Membrane Protein 1
    Tauopathies
    tau Proteins
    Neurofibrillary Tangles
    Amyloid beta-Peptides
    Neurodegenerative Diseases
    Disease Progression
    Down-Regulation
    Phenotype
    resveratrol

    Keywords

    • Alzheimer's disease
    • BAG2
    • Curcumin
    • Polyphenol
    • Tau

    ASJC Scopus subject areas

    • Neuroscience(all)

    Cite this

    Curcumin-induced upregulation of the anti-tau cochaperone BAG2 in primary rat cortical neurons. / Patil, Sachin P.; Tran, Nhung; Geekiyanage, Hirosha; Liu, Li; Chan, Christina.

    In: Neuroscience Letters, Vol. 554, 25.10.2013, p. 121-125.

    Research output: Research - peer-reviewArticle

    Patil, Sachin P. ; Tran, Nhung ; Geekiyanage, Hirosha ; Liu, Li ; Chan, Christina. / Curcumin-induced upregulation of the anti-tau cochaperone BAG2 in primary rat cortical neurons. In: Neuroscience Letters. 2013 ; Vol. 554. pp. 121-125
    @article{2c8f2ea956aa4e72abd62311131388c7,
    title = "Curcumin-induced upregulation of the anti-tau cochaperone BAG2 in primary rat cortical neurons",
    abstract = "Alzheimer's disease (AD) is a progressive, neurodegenerative disease characterized by extracellular deposits of amyloid beta (Aβ) protein and intracellular neurofibrillary tangles of hyperphosphorylated tau protein. Various studies suggest that the tau tangle pathology, which lies downstream to Aβ pathology, is essential to produce AD-associated clinical phenotype and thus treatments targeting tau pathology may prevent or delay disease progression effectively. In this context, our present study examined three polyphenol compounds (curcumin, EGCG and resveratrol) for their possible activity against two endogenous proteins (BAG2 and LAMP1) that are shown to play a vital role in clearing tau tangles from neurons. Human epidemiological and animal data suggest potential positive effects of these polyphenols against AD. Here, primary rat cortical neurons treated with these polyphenols significantly up-regulated BAG2 levels at different concentrations, while only EGCG upregulated LAMP1 levels, although at higher concentrations. Importantly, curcumin doubled BAG2 levels at low micromolar concentrations that are clinically relevant. In addition, curcumin also downregulated levels of phosphorylated tau, which may be potentially attributed to the curcumin-induced upregulation in BAG2 levels in the neurons. The present results demonstrate novel activity of polyphenol curcumin in up-regulating an anti-tau cochaperone BAG2 and thus, suggest probable benefit of curcumin against AD-associated tauopathy.",
    keywords = "Alzheimer's disease, BAG2, Curcumin, Polyphenol, Tau",
    author = "Patil, {Sachin P.} and Nhung Tran and Hirosha Geekiyanage and Li Liu and Christina Chan",
    year = "2013",
    month = "10",
    doi = "10.1016/j.neulet.2013.09.008",
    volume = "554",
    pages = "121--125",
    journal = "Neuroscience Letters",
    issn = "0304-3940",
    publisher = "Elsevier Ireland Ltd",

    }

    TY - JOUR

    T1 - Curcumin-induced upregulation of the anti-tau cochaperone BAG2 in primary rat cortical neurons

    AU - Patil,Sachin P.

    AU - Tran,Nhung

    AU - Geekiyanage,Hirosha

    AU - Liu,Li

    AU - Chan,Christina

    PY - 2013/10/25

    Y1 - 2013/10/25

    N2 - Alzheimer's disease (AD) is a progressive, neurodegenerative disease characterized by extracellular deposits of amyloid beta (Aβ) protein and intracellular neurofibrillary tangles of hyperphosphorylated tau protein. Various studies suggest that the tau tangle pathology, which lies downstream to Aβ pathology, is essential to produce AD-associated clinical phenotype and thus treatments targeting tau pathology may prevent or delay disease progression effectively. In this context, our present study examined three polyphenol compounds (curcumin, EGCG and resveratrol) for their possible activity against two endogenous proteins (BAG2 and LAMP1) that are shown to play a vital role in clearing tau tangles from neurons. Human epidemiological and animal data suggest potential positive effects of these polyphenols against AD. Here, primary rat cortical neurons treated with these polyphenols significantly up-regulated BAG2 levels at different concentrations, while only EGCG upregulated LAMP1 levels, although at higher concentrations. Importantly, curcumin doubled BAG2 levels at low micromolar concentrations that are clinically relevant. In addition, curcumin also downregulated levels of phosphorylated tau, which may be potentially attributed to the curcumin-induced upregulation in BAG2 levels in the neurons. The present results demonstrate novel activity of polyphenol curcumin in up-regulating an anti-tau cochaperone BAG2 and thus, suggest probable benefit of curcumin against AD-associated tauopathy.

    AB - Alzheimer's disease (AD) is a progressive, neurodegenerative disease characterized by extracellular deposits of amyloid beta (Aβ) protein and intracellular neurofibrillary tangles of hyperphosphorylated tau protein. Various studies suggest that the tau tangle pathology, which lies downstream to Aβ pathology, is essential to produce AD-associated clinical phenotype and thus treatments targeting tau pathology may prevent or delay disease progression effectively. In this context, our present study examined three polyphenol compounds (curcumin, EGCG and resveratrol) for their possible activity against two endogenous proteins (BAG2 and LAMP1) that are shown to play a vital role in clearing tau tangles from neurons. Human epidemiological and animal data suggest potential positive effects of these polyphenols against AD. Here, primary rat cortical neurons treated with these polyphenols significantly up-regulated BAG2 levels at different concentrations, while only EGCG upregulated LAMP1 levels, although at higher concentrations. Importantly, curcumin doubled BAG2 levels at low micromolar concentrations that are clinically relevant. In addition, curcumin also downregulated levels of phosphorylated tau, which may be potentially attributed to the curcumin-induced upregulation in BAG2 levels in the neurons. The present results demonstrate novel activity of polyphenol curcumin in up-regulating an anti-tau cochaperone BAG2 and thus, suggest probable benefit of curcumin against AD-associated tauopathy.

    KW - Alzheimer's disease

    KW - BAG2

    KW - Curcumin

    KW - Polyphenol

    KW - Tau

    UR - http://www.scopus.com/inward/record.url?scp=84884724033&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84884724033&partnerID=8YFLogxK

    U2 - 10.1016/j.neulet.2013.09.008

    DO - 10.1016/j.neulet.2013.09.008

    M3 - Article

    VL - 554

    SP - 121

    EP - 125

    JO - Neuroscience Letters

    T2 - Neuroscience Letters

    JF - Neuroscience Letters

    SN - 0304-3940

    ER -